Jyoti Baharani

ORCID: 0000-0003-4539-9927
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Central Venous Catheters and Hemodialysis
  • Palliative Care and End-of-Life Issues
  • Acute Kidney Injury Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Organ Donation and Transplantation
  • Chronic Kidney Disease and Diabetes
  • Healthcare Policy and Management
  • Patient-Provider Communication in Healthcare
  • Diversity and Career in Medicine
  • Renal Diseases and Glomerulopathies
  • Intensive Care Unit Cognitive Disorders
  • Vascular Procedures and Complications
  • Patient Satisfaction in Healthcare
  • Renal Transplantation Outcomes and Treatments
  • Innovations in Medical Education
  • Muscle and Compartmental Disorders
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Pharmacological Effects and Toxicity Studies
  • Childhood Cancer Survivors' Quality of Life
  • Epilepsy research and treatment
  • Antimicrobial Resistance in Staphylococcus
  • Blood Pressure and Hypertension Studies

University Hospitals Birmingham NHS Foundation Trust
2018-2025

Heartlands Hospital
2015-2025

NIHR Surgical Reconstruction and Microbiology Research Centre
2020-2024

University of Manchester
2024

National Heart Foundation Hospital & Research Institute
2024

West Midlands Deanery
2023

National Kidney Foundation
2023

Wayne State University
2023

Creative Commons
2023

Heart of England NHS Foundation Trust
2011-2019

Katie Wong David Pitcher Fiona Braddon Lewis Downward Retha Steenkamp and 95 more Nicholas M. P. Annear Jonathan Barratt Coralie Bingham Constantina Chrysochou Richard J. Coward David Game Siân Griffin Matt Hall Sally Johnson Durga Kanigicherla Fiona Karet Frankl David Kavanagh Larissa Kerecuk Eamonn R. Maher Shabbir H. Moochhala Jenny Pinney John A. Sayer Roslyn Simms Smeeta Sinha Shalabh Srivastava Frederick W.K. Tam Andrew Neil Turner Stephen B. Walsh Aoife Waters Patricia D. Wilson Edwin K.S. Wong C. Mark Taylor Dorothea Nitsch Moin A. Saleem Detlef Böckenhauer Kate Bramham Daniel P. Gale Sharirose Abat Shazia Adalat Joy O. Agbonmwandolor Zubaidah Ahmad Abdulfattah Alejmi Rashid Almasarwah Nicholas M. P. Annear Ellie Asgari Amanda Ayers Jyoti Baharani Gowrie Balasubramaniam Felix Kpodo Tarun Bansal Alison Barratt Jonathan Barratt Megan Bates N K Bayne Janet Bendle Sarah Benyon Carsten Bergmann Sunil Bhandari Coralie Bingham Preetham Boddana Sally L. Bond Fiona Braddon Kate Bramham Angela Branson Stephen Brearey Vicky Brocklebank Sharanjit Budwal Conor Byrne Hugh Cairns Brian Camilleri Gary Campbell A. Capell Margaret Carmody Marion Carson Tracy Cathcart Christine Catley Karine Cesar Melanie Chan Houda Chea James Chess Chee Kay Cheung Katy-Jane Chick Nihil Chitalia Martin Christian Constantina Chrysochou Katherine Clark Christopher L. Clayton Rhian Clissold Helen Cockerill Joshua Coelho Elizabeth Colby Viv Colclough Eileen Conway H. Terence Cook Wendy L. Cook Theresa Cooper Richard J. Coward Sarah Crosbie Gabor Cserep Anjali Date

BackgroundIndividuals with rare kidney diseases account for 5–10% of people chronic disease, but constitute more than 25% patients receiving replacement therapy. The National Registry Rare Kidney Diseases (RaDaR) gathers longitudinal data from these conditions, which we used to study disease progression and outcomes death failure.MethodsPeople aged 0–96 years living 28 types were recruited 108 UK renal care facilities. primary cumulative incidence mortality failure in individuals diseases,...

10.1016/s0140-6736(23)02843-x article EN cc-by The Lancet 2024-03-01

Background. There is little information on factors influencing patient choice of renal replacement modality (RRM) in the UK. Pre-dialysis education programmes have been associated with increased uptake peritoneal dialysis (PD) other countries but their relevance informing within UK centres has not extensively studied. In this study, we examined how different treatment modalities [haemodialysis (HD), PD and conservative management (CM)] influenced by personal demographic parameters.

10.1093/ndt/gfr452 article EN Nephrology Dialysis Transplantation 2011-08-23

Acute renal failure (ARF) is a diverse condition with no standardized definition and managed in several sub-specialty areas within hospitals. Its incidence aetiology are unknown studies show wide range of incidences. ARF becoming more common as the population ages leading to hypothesis that much higher than previous estimates.This prospective study investigated incidence, outcomes based on classification treated by replacement therapy (RRT) all hospitals where such treatment takes place....

10.1093/ndt/gfm264 article EN Nephrology Dialysis Transplantation 2007-05-22

There have been few studies of earlier systematic intervention to reduce the impact acute kidney injury (AKI). In 2009, we piloted an AKI outreach service with a before and after study, report on study its longer-term follow-up.AKI patients were identified using laboratory delta check for creatinine 75%. 4-week phase received standard care. consecutive 7-week team nephrology doctors nurses reviewed all alerts twice daily, 5 days week. The primary clinical caring patient was called be given...

10.1093/ndt/gfu316 article EN Nephrology Dialysis Transplantation 2014-10-21

Severe acute kidney injury (AKI) occurs in 2-7% of all hospital admissions and is an independent poor prognostic marker. Nevertheless, information on the long-term outcome AKI factors influencing this limited.To describe short- patients requiring renal replacement therapy (RRT) for severe to examine affecting patient survival recovery.Single centre retrospective analysis 481 consecutive over a period 39 months.12 months.overall mortality RRT dependency at 30 days, 90 days 1 year.Survival...

10.1093/qjmed/hcr133 article EN QJM 2011-08-22

As a result of difficulties related to their illness, diagnosis and treatment, patients with end-stage renal disease experience significant emotional psychological problems, which untreated can have considerable negative impact on health wellbeing. Despite evidence that desire improved support, management psychosocial particularly at the lower-level, remains sub-optimal. There is limited understanding specific support need want, from whom, when, also lack data what helps hinders staff in...

10.1186/s12882-016-0327-2 article EN cc-by BMC Nephrology 2016-08-02

Lower-level emotional and psychological difficulties ('distress') in patients with end stage renal disease (ESRD), can lead to reduced quality of life poor clinical outcomes. National guidelines mandate provision support for yet little is known about the that may require, or challenges staff experience identifying responding patient distress.Mixed methods study units at four NHS Trusts West Midlands, UK involving cross-sectional surveys ESRD unit semi-structured interviews 46...

10.1186/s12913-019-4808-4 article EN cc-by BMC Health Services Research 2019-12-01

Objectives To explore patient perceptions and experiences of mild-to-moderate emotional distress the support offered by kidney units to patients with end-stage disease. Methods In-depth, semi-structured qualitative interviews (n = 46) being treated for disease in four hospital Trusts, data analysed thematically. Results Patients described multiple sources talked about substantial burden that challenges raised their ability manage condition develop coping strategies. Many did not feel it...

10.1371/journal.pone.0241629 article EN cc-by PLoS ONE 2020-11-05
Maria Pippias Gaetano Alfano Dearbhla Kelly María José Soler Letizia De Chiara and 87 more Timothy O. Olanrewaju Silvia Arruebo Aminu K. Bello Fergus Caskey Sandrine Damster Jo‐Ann Donner Vivekanand Jha David W. Johnson Adeera Levin Charu Malik Masaomi Nangaku Ikechi G. Okpechi Marcello Tonelli Feng Ye Rosanna Coppo Liz Lightstone Atefeh Amouzegar Hans‐Joachim Anders Jyoti Baharani Debasish Banerjee Boris Bikbov Edwina A. Brown Yeoungjee Cho Kathleen Claes Naomi Clyne Mogamat Razeen Davids Sara N. Davison Hassane M. Diongole Smita Divyaveer Gavin Dreyer Jan Dudley Udeme E. Ekrikpo Isabelle Éthier Rhys Evans Stanley Fan Winston Wing‐Shing Fung Maurizio Gallieni Anukul Ghimire Ghenette Houston Htay Htay Kwaifa Salihu Ibrahim Georgina Irish Kailash Jindal Arif Khwaja Rowena Lalji Vassilios Liakopoulos Valérie A. Luyckx Manuel Macı́a Hans‐Peter Marti Piergiorgio Messa Thomas Müller Aisha M. Nalado Brendon L. Neuen Dorothea Nitsch Fernando Nolasco Rainer Oberbauer Mohamed A. Osman Αikaterini Papagianni Анна Петрова Giorgina Barbara Piccoli Liam Plant Giuseppe Remuzzi Parnian Riaz Joris J. T. H. Roelofs Michael A. Rudnicki Syed Saad Aminu Muhammad Sakajiki Johannes B. Scheppach Emily See Rukshana Shroff Marit D. Solbu Stephen M. Sozio Giovanni FM Strippoli Maarten W. Taal James Tataw Ashu Sophanny Tiv Somkanya Tungsanga Jeroen B. van der Net Raymond Vanholder Andrea K. Viecelli Katie Vinen Bruno Vogt Marina Wainstein Talia Weinstein David C. Wheeler Emily K. Yeung Deenaz Zaidi

10.1016/j.kisu.2024.01.008 article EN Kidney International Supplements 2024-04-01

This paper discusses the features of an effective long-term haemodialysis catheter and identifies some complications that improved dialysis design can overcome. It benefits using Glidepath TM Long Term Haemodialysis Catheter illustrates these with case studies feedback from patients

10.12968/jokc.2025.10.1.8 article EN Journal of Kidney Care 2025-01-02

Background: Patients with chronic kidney disease (CKD) face an elevated risk of cardiovascular (CVD), particularly those estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m². Aims: To assess low-density lipoprotein cholesterol (LDL-C) values and the proportion pre-dialysis patients achieving national international targets. Methods: This was a retrospective audit (May–October 2024) 272 aged >18 years attending clinic (estimated m2) at Renal Unit, Birmingham Heartlands...

10.3390/hearts6020014 article EN cc-by Hearts 2025-05-31

Cognitive impairment (CI) is very common condition that occurs in haemodialysis patients and it associated with reduced functional capacity mortality. We assessed the change cognitive function during risk factors.All ≥50 years, on for ≥3 months, no dementia from 2 dialysis centres were selected. Cognition was before after a session using parallel versions of Montreal Assessment (MOCA) tool. Multiple regression used to examine potential confounders.Eight-two completed both tests - median age...

10.1159/000485961 article EN Blood Purification 2018-01-01

Some Indoasian (IA) patients with established renal failure travel abroad for commercial kidney transplantation. We compared the 1-year outcomes of IA from one UK region who received overseas transplants receiving local living donor (LD) transplantation, deceased (DD) and dialysis.Between 1996 2006, 40 adults were transplanted overseas; 38 IA, follow-up data available on 36 patients. Forty LD transplants, 156 DD locally. A cohort 120 prospective dialysis was also used as a comparator...

10.1097/tp.0b013e3181da6019 article EN Transplantation 2010-03-30

Objectives To explore staff perceptions of barriers to the identification mild moderate distress and provision emotional support in patients with end-stage renal disease. Methods Qualitative semi-structured interviews two hospitals (n = 31), data analysed using a hybrid approach combining thematic analysis aspects grounded theory. Results Staff appeared very aware that many disease experience distress, most thought distressed should be helped as part routine care. However, practice was...

10.1371/journal.pone.0225269 article EN cc-by PLoS ONE 2019-11-21

Objectives To assess the prevalence of mild-to-moderate distress in patients with end-stage renal disease (ESRD) and determine association between patient characteristics. Design Cross-sectional survey using emotion thermometer problem list. Setting Renal units four hospital Trusts West Midlands, UK. Participants Adult stage 5 chronic kidney who were: (1) On prerenal replacement therapy. (2) dialysis for less than 2 years. (3) years or more (4) With a functioning transplant. Outcomes The...

10.1136/bmjopen-2018-027982 article EN cc-by BMJ Open 2019-05-01
Coming Soon ...